GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human apom in complex with myristic acid

Analyse Crystal structure of human apom in complex with myristic acid in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2WEW
Type
protein
Length
170 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Apolipoprotein M
UniProt
O95445
Ligands
MYR
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AApolipoprotein Mprotein17015% helix, 40% strandO95445

Ligands and binding sites

  • MYR · Myristic acid · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12190.730.8732MYR
2510.410.8314empty

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 2WEW · Crystal structure of human apoM in complex with myristic acid · the same entry in another collection · chain A against A, TM-score 1.00
  • O95445 · AlphaFold monomer V2.0 prediction for apolipoprotein M (O95445) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.